Pylarify (piflufolastat f 18) injection
Ended Awarded Last action
- Contract number
- 36C24826N0071
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 8
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,201,704
Award facts
- Contract value 100% obligated
- $1,201,703.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $299,524 | |
| Supplemental Agreement for work within scope | $451,090 | |
| Original award | $451,090 |
About this award
Veterans Integrated Service Network 8 issued a BPA call to Progenics Pharmaceuticals Inc. for PYLARIFY (piflufolastat F-18) injection with a ceiling value of $1,201,703.76 and an award date of October 1, 2025.
The call is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and represents a modification to increase quantities of radiopharmaceutical product. PYLARIFY is a diagnostic imaging agent used in positron emission tomography scans for prostate cancer detection and localization in federal healthcare settings. Performance occurs at the awardee's facility in North Billerica, Massachusetts, with completion scheduled for September 30, 2026. The order is priced on a firm fixed-price basis with no set-aside designation.
Quick answers
Who was awarded contract 36C24826N0071?
36C24826N0071 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 8 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C24826N0071 worth?
The government has obligated $1,201,704 on 36C24826N0071.
Is contract 36C24826N0071 an order under another contract?
Yes. 36C24826N0071 is a BPA call under 36F79719D0170-36C24824A0038, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24826N0071 competed?
The extent of competition for 36C24826N0071 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award